Clarivate offer service "OFF-X"

OFF-X monitors and anticipates toxicology and safety signals, helping mitigate safety liabilities and de-risk assets across every phase of drug R&D and post-marketing surveillance. It supports confident development and investment decisions through comprehensive translational safety intelligence, providing integrated preclinical toxicity data, clinical and pharmacovigilance adverse-event data, visualizations, and preclinical safety analytics - benchmarking safety profiles and assessing risk, predicting preclinical toxicity and anticipating adverse events, and supporting signal detection, prioritization, and evaluation.